Filtering by:
LymphomaFDA Approves Poteligeo (Mogamulizumab) for Lymphoma of the Skin
The US Food and Drug Administration (FDA) has approved Poteligeo (mogamulizumab) to treat people with some types of skin lymphoma.
FDA Approves Calquence (Acalabrutinib) for Mantle Cell Lymphoma
The US Food and Drug Administration (FDA) has approved a targeted therapy for treating certain adults with mantle cell lymphoma.
FDA Approves Yescarta (Axicabtagene Ciloleucel) for Adults with Certain Lymphomas
The US Food and Drug Administration (FDA) has approved Yescarta (axicabtagene ciloleucel) to treat adults with certain types of large B-Cell lymphoma.
Caring for Children with Cancer
The types of cancers that develop in children are often different from the types that develop in adults. Even when kids have a cancer type that adults get too, it is often treated differently.
FDA Updates Guidance About Breast Implant Link to Lymphoma
The US Food and Drug Administration (FDA) says women with breast implants should have regular checks for the possibility of a certain type of lymphoma.
World Health Organization Links 8 More Cancer Types to Excess Weight
The International Agency for Research on Cancer (IARC), part of the World Health Organization, has added 8 types of cancer to those it had previously linked to being overweight or obese.
FDA Approves Opdivo for Hard-to-Treat Hodgkin Lymphoma
The FDA granted accelerated approval to Opdivo (nivolumab) for Hodgkin lymphoma after treatment with stem cell transplant and post-transplant drug Adcentris.
Experts Gather for Annual Meeting on Blood Diseases
More than 25,000 hematology specialists from all over the world are in Orlando, Florida this week for the annual meeting of the American Society of Hematology (ASH).